Bisphenol A alters the self-renewal and differentiation capacity of human bone-marrow-derived mesenchymal stem cells

References

• Schug TT, Janesick A, Blumberg B, Heindel JJ. Endocrine disrupting chemicals and disease susceptibility. J Steroid Biochem Mol Biol 2011; 127:204-15; PMID:21899826; http://dx.doi.org/10.1016/j.jsbmb.2011.08.007
   PubMed Web of Science ®Google Scholar
• Swedenborg E, Ruegg J, Makela S, Pongratz I. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J Mol Endocrinol 2009; 43:1-10; PMID:19211731; http://dx.doi.org/10.1677/JME-08-0132
   PubMed Web of Science ®Google Scholar
• De Coster S, van Larebeke N. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health 2012; 2012:713696; PMID:22991565; http://dx.doi.org/10.1155/2012/713696
   PubMedGoogle Scholar
• Stel J, Legler J. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals. Endocrinology 2015; 156:3466-72; PMID:26241072; http://dx.doi.org/10.1210/en.2015-1434
   PubMed Web of Science ®Google Scholar
• Prins GS, Calderon-Gierszal EL, Hu WY. Stem Cells as Hormone Targets That Lead to Increased Cancer Susceptibility. Endocrinology 2015; 156:3451-7; PMID:26241068; http://dx.doi.org/10.1210/en.2015-1357
   PubMed Web of Science ®Google Scholar
• Hormann AM, Vom Saal FS, Nagel SC, Stahlhut RW, Moyer CL, Ellersieck MR, Welshons WV, Toutain PL, Taylor JA. Holding thermal receipt paper and eating food after using hand sanitizer results in high serum bioactive and urine total levels of bisphenol A (BPA). PloS one 2014; 9:e110509; PMID:25337790; http://dx.doi.org/10.1371/journal.pone.0110509
   PubMed Web of Science ®Google Scholar
• Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 2008; 116:39-44; PMID:18197297; http://dx.doi.org/10.1289/ehp.10753
   PubMed Web of Science ®Google Scholar
• Liao C, Kannan K. Determination of free and conjugated forms of bisphenol A in human urine and serum by liquid chromatography-tandem mass spectrometry. Environ Sci Technol 2012; 46:5003-9; PMID:22489688; http://dx.doi.org/10.1021/es300115a
   PubMed Web of Science ®Google Scholar
• Vandenberg LN, Chahoud I, Heindel JJ, Padmanabhan V, Paumgartten FJ, Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ Health Perspect 2010; 118:1055-70; PMID:20338858; http://dx.doi.org/10.1289/ehp.0901716
   PubMed Web of Science ®Google Scholar
• Sheng ZG, Tang Y, Liu YX, Yuan Y, Zhao BQ, Chao XJ, Zhu BZ. Low concentrations of bisphenol a suppress thyroid hormone receptor transcription through a nongenomic mechanism. Toxicol Appl Pharmacol 2012; 259:133-42; PMID:22227104; http://dx.doi.org/10.1016/j.taap.2011.12.018
   PubMed Web of Science ®Google Scholar
• Richter CA, Taylor JA, Ruhlen RL, Welshons WV, Vom Saal FS. Estradiol and Bisphenol A stimulate androgen receptor and estrogen receptor gene expression in fetal mouse prostate mesenchyme cells. Environ Health Perspect 2007; 115:902-8; PMID:17589598; http://dx.doi.org/10.1289/ehp.9804
   PubMed Web of Science ®Google Scholar
• Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, Hataya Y, Shimatsu A, Kuzuya H, Nakao K. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 2002; 87:5185-90; PMID:12414890; http://dx.doi.org/10.1210/jc.2002-020209
   PubMed Web of Science ®Google Scholar
• Vandenberg LN, Ehrlich S, Belcher SM, Ben-Jonathan N, Dolinoy DC, Hugo ER, Hunt PA, Newbold RR, Rubin BS, Saili KS, et al. Low dose effects of bisphenol A. Endocrine Disruptors 2013; 1:e26490; PMID:NOT_FOUND; http://dx.doi.org/10.4161/endo.26490
   PubMedGoogle Scholar
• Fujimoto VY, Kim D, Vom Saal FS, Lamb JD, Taylor JA, Bloom MS. Serum unconjugated bisphenol A concentrations in women may adversely influence oocyte quality during in vitro fertilization. Fertil Steril 2011; 95:1816-9; PMID:21122836; http://dx.doi.org/10.1016/j.fertnstert.2010.11.008
   PubMed Web of Science ®Google Scholar
• Ehrlich S, Williams PL, Missmer SA, Flaws JA, Ye X, Calafat AM, Petrozza JC, Wright D, Hauser R. Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod 2012; 27:3583-92; PMID:23014629; http://dx.doi.org/10.1093/humrep/des328
   PubMed Web of Science ®Google Scholar
• Ehrlich S, Williams PL, Missmer SA, Flaws JA, Berry KF, Calafat AM, Ye X, Petrozza JC, Wright D, Hauser R. Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization. Environ Health Perspect 2012; 120:978-83; PMID:22484414; http://dx.doi.org/10.1289/ehp.1104307
   PubMed Web of Science ®Google Scholar
• Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. Jama 2008; 300:1303-10; PMID:18799442; http://dx.doi.org/10.1001/jama.300.11.1303
   PubMed Web of Science ®Google Scholar
• Carwile JL, Michels KB. Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res 2011; 111:825-30; PMID:21676388; http://dx.doi.org/10.1016/j.envres.2011.05.014
   PubMed Web of Science ®Google Scholar
• Trasande L, Attina TM, Blustein J. Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. Jama 2012; 308:1113-21; PMID:22990270; http://dx.doi.org/10.1001/2012.jama.11461
   PubMed Web of Science ®Google Scholar
• Melzer D, Osborne NJ, Henley WE, Cipelli R, Young A, Money C, McCormack P, Luben R, Khaw KT, Wareham NJ, et al. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 2012; 125:1482-90; PMID:22354940; http://dx.doi.org/10.1161/CIRCULATIONAHA.111.069153
   PubMed Web of Science ®Google Scholar
• Ohlstein JF, Strong AL, McLachlan JA, Gimble JM, Burow ME, Bunnell BA. Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells. J Mol Endocrinol 2014; 53:345-53; PMID:25143472; http://dx.doi.org/10.1530/JME-14-0052
   PubMed Web of Science ®Google Scholar
• Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 2005; 84:319-27; PMID:15659569; http://dx.doi.org/10.1093/toxsci/kfi088
   PubMed Web of Science ®Google Scholar
• Boucher JG, Boudreau A, Atlas E. Bisphenol A induces differentiation of human preadipocytes in the absence of glucocorticoid and is inhibited by an estrogen-receptor antagonist. Nutr Diabetes 2014; 4:e102; PMID:24418828; http://dx.doi.org/10.1038/nutd.2013.43
   PubMedGoogle Scholar
• Wang J, Sun B, Hou M, Pan X, Li X. The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11beta-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children. Int J Obesity (2005) 2013; 37:999-1005; PMID:23090578; http://dx.doi.org/10.1038/ijo.2012.173
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pardo VM, Aristizabal JA, Jaimes D, Quijano SM, De los Reyes I, Herrera MV, Solano J, Vernot JP. Mesenchymal stem cells promote leukaemic cells aberrant phenotype from B-cell acute lymphoblastic leukaemia. Hematol Oncol Stem Cell Ther 2013; 6:89-100; PMID:24161606; http://dx.doi.org/10.1016/j.hemonc.2013.09.002
   PubMedGoogle Scholar
• Hanoun M, Zhang D, Mizoguchi T, Pinho S, Pierce H, Kunisaki Y, Lacombe J, Armstrong SA, Duhrsen U, Frenette PS. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell 2014; 15:365-75; PMID:25017722; http://dx.doi.org/10.1016/j.stem.2014.06.020
   PubMed Web of Science ®Google Scholar
• Welshons WV, Nagel SC, Vom Saal FS. Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006; 147:S56-69; PMID:16690810; http://dx.doi.org/10.1210/en.2005-1159
   PubMed Web of Science ®Google Scholar
• Pupo M, Pisano A, Lappano R, Santolla MF, De Francesco EM, Abonante S, Rosano C, Maggiolini M. Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ Health Perspect 2012; 120:1177-82; PMID:22552965; http://dx.doi.org/10.1289/ehp.1104526
   PubMed Web of Science ®Google Scholar
• Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Ando S, Maggiolini M. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 2006; 70:1414-23; PMID:16835357; http://dx.doi.org/10.1124/mol.106.026344
   PubMed Web of Science ®Google Scholar
• Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Ando S, et al. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 2007; 67:1859-66; PMID:17308128; http://dx.doi.org/10.1158/0008-5472.CAN-06-2909
   PubMed Web of Science ®Google Scholar
• Maggiolini M, Picard D. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 2010; 204:105-14; PMID:19767412; http://dx.doi.org/10.1677/JOE-09-0242
   PubMed Web of Science ®Google Scholar
• Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005; 146:624-32; PMID:15539556; http://dx.doi.org/10.1210/en.2004-1064
   PubMed Web of Science ®Google Scholar
• Thomas P, Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol 2006; 102:175-9; PMID:17088055; http://dx.doi.org/10.1016/j.jsbmb.2006.09.017
   PubMed Web of Science ®Google Scholar
• Frigo DE, Burow ME, Mitchell KA, Chiang TC, McLachlan JA. DDT and its metabolites alter gene expression in human uterine cell lines through estrogen receptor-independent mechanisms. Environ Health Perspect 2002; 110:1239-45; PMID:12460804; http://dx.doi.org/10.1289/ehp.021101239
   PubMed Web of Science ®Google Scholar
• Frigo DE, Tang Y, Beckman BS, Scandurro AB, Alam J, Burow ME, McLachlan JA. Mechanism of AP-1-mediated gene expression by select organochlorines through the p38 MAPK pathway. Carcinogenesis 2004; 25:249-61; PMID:14604893; http://dx.doi.org/10.1093/carcin/bgh009
   PubMed Web of Science ®Google Scholar
• Frigo DE, Vigh KA, Struckhoff AP, Elliott S, Beckman BS, Burow ME, McLachlan JA. Xenobiotic-induced TNF-alpha expression and apoptosis through the p38 MAPK signaling pathway. Toxicology letters 2005; 155:227-38; PMID:15603917; http://dx.doi.org/10.1016/j.toxlet.2004.09.008
   PubMed Web of Science ®Google Scholar
• Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliott S, Collins-Burow BM, Salvo VA, Zhu Y, Melnik LI, et al. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Mol Endocrinol 2006; 20:971-83; PMID:16410316; http://dx.doi.org/10.1210/me.2004-0075
   PubMed Web of Science ®Google Scholar
• Bratton MR, Frigo DE, Vigh-Conrad KA, Fan D, Wadsworth S, McLachlan JA, Burow ME. Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase. Carcinogenesis 2009; 30:106-13; PMID:18791200; http://dx.doi.org/10.1093/carcin/bgn213
   PubMed Web of Science ®Google Scholar
• Bratton MR, Frigo DE, Segar HC, Nephew KP, McLachlan JA, Wiese TE, Burow ME. The organochlorine o,p′-DDT plays a role in coactivator-mediated MAPK crosstalk in MCF-7 breast cancer cells. Environ Health Perspect 2012; 120:1291-6; PMID:22609851; http://dx.doi.org/10.1289/ehp.1104296
   PubMed Web of Science ®Google Scholar
• Strong AL, Shi Z, Strong MJ, Miller DF, Rusch DB, Buechlein AM, Flemington EK, McLachlan JA, Nephew KP, Burow ME, et al. Effects of the Endocrine-Disrupting Chemical DDT on Self-Renewal and Differentiation of Human Mesenchymal Stem Cells. Environ Health Perspect 2014; 123(1):42-8; PMID:25014179
   PubMed Web of Science ®Google Scholar
• Miller DFB, Yan PS, Buechlein A, Rodriguez BA, Yilmaz AS, Goel S, Lin H, Collins-Burow B, Rhodes LV, Braun C, et al. Methods http://dx.doi.org/10.1016/j.ymeth.2013.03.0232013
   Google Scholar
• Miller DF, Yan PS, Buechlein A, Rodriguez BA, Yilmaz AS, Goel S, Lin H, Collins-Burow B, Rhodes LV, Braun C, et al. A new method for stranded whole transcriptome RNA-seq. Methods 2013; 63:126-34; PMID:23557989; http://dx.doi.org/10.1016/j.ymeth.2013.03.023
   PubMed Web of Science ®Google Scholar
• Miller DF, Yan PX, Fang F, Buechlein A, Ford JB, Tang H, Huang TH, Burow ME, Liu Y, Rusch DB, et al. Stranded Whole Transcriptome RNA-Seq for All RNA Types. Cur Protoc Hum Genet 2015; 84:11.4.1-.4.23; PMID:25599667
   PubMedGoogle Scholar